88 related articles for article (PubMed ID: 2530592)
1. Effect of cyclooxygenase blockade on the beneficial actions of nicorandil in the stunned myocardium of dogs.
Gross GJ; Pieper GM
Pharmacology; 1989; 38(6):341-51. PubMed ID: 2530592
[TBL] [Abstract][Full Text] [Related]
2. Effects of nicorandil on coronary circulation and myocardial ischemia.
Gross G; Pieper G; Farber NE; Warltier D; Hardman H
Am J Cardiol; 1989 Jun; 63(21):11J-17J. PubMed ID: 2525319
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium.
Gross GJ; Pieper GM; Warltier DC
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
Auchampach JA; Cavero I; Gross GJ
J Cardiovasc Pharmacol; 1992; 20(5):765-71. PubMed ID: 1280739
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Gross GJ; Warltier DC; Hardman HF
J Cardiovasc Pharmacol; 1987 Nov; 10(5):535-42. PubMed ID: 2447402
[TBL] [Abstract][Full Text] [Related]
6. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of nicorandil.
Gross GJ; Auchampach JA; Maruyama M; Warltier DC; Pieper GM
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S22-8. PubMed ID: 1282172
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
[TBL] [Abstract][Full Text] [Related]
9. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine.
Lamping KA; Gross GJ
J Cardiovasc Pharmacol; 1985; 7(1):158-66. PubMed ID: 2580137
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin redirection by thromboxane synthetase inhibition. Attenuation of myocardial stunning in canine heart.
Farber NE; Gross GJ
Circulation; 1990 Jan; 81(1):369-80. PubMed ID: 2297841
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
Zaugg CE; Hornstein PS; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
Circulation; 1996 Aug; 94(4):742-7. PubMed ID: 8772697
[TBL] [Abstract][Full Text] [Related]
12. Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent.
Shimshak TM; Preuss KC; Gross GJ; Brooks HL; Warltier DC
Cardiovasc Res; 1986 Aug; 20(8):621-6. PubMed ID: 2947685
[TBL] [Abstract][Full Text] [Related]
13. SG-75 induction of increased coronary outflow and PGE1 from ischemic areas in dogs with experimental myocardial infarction.
Ogawa K; Enomoto I; Ito T; Ban M; Hashimoto H; Sakai K
Jpn Heart J; 1982 Jul; 23(4):603-11. PubMed ID: 6215507
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
Tanabe M; Terashita Z; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
[TBL] [Abstract][Full Text] [Related]
15. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
Farber NE; Pieper GM; Gross GJ
Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
Przyklenk K; Kloner RA
Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
[TBL] [Abstract][Full Text] [Related]
17. Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate.
Pieper GM; Gross GJ
Circulation; 1987 Oct; 76(4):916-28. PubMed ID: 2958176
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of recovery of mitochondrial function after coronary reperfusion by various coronary dilating drugs in canine hearts.
Hanaki Y; Sugiyama S; Ajioka M; Kondo T; Fukushima A; Ozawa T
J Cardiovasc Pharmacol; 1989 Feb; 13(2):336-41. PubMed ID: 2468967
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicorandil and nifedipine on protection of ischemic myocardium.
Lamping KA; Christensen CW; Pelc LR; Warltier DC; Gross GJ
J Cardiovasc Pharmacol; 1984; 6(3):536-42. PubMed ID: 6202983
[TBL] [Abstract][Full Text] [Related]
20. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
Lamping KA; Warltier DC; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
